Inova Health System

The addition of Inova Health System of Northern Virginia and its five major hospitals provides yet another strength to the Johns Hopkins Clinical Research Network in terms of established research programs, patient population and specialty collaborations, especially in the area of pediatrics, neurosciences, cardiovascular, oncology and genomics medicine. Dr. John E. Niederhuber, Inova’s EVP and CEO of the Inova Translational Medicine Institute and Professor of Oncology and Surgery at the Johns Hopkins University School of Medicine, is co-director of the Johns Hopkins Clinical Research Network and sits on the Executive Committee of the JHCRN. Dr. Niederhuber was formerly Director of the National Cancer Institute and Director of the University of Wisconsin Comprehensive Cancer Center. He is a member of the Institute of Medicine of the National Academy of Sciences.

The Inova Health System provides medical services for a catchment basin of over 3.0 million people in Northern Virginia and Southwestern Maryland. They have over 3000 physicians on their medical staff. The Inova Fairfax Medical Center is composed of over 800 beds, including a Pediatrics Hospital, and is the primary site for managing clinical and laboratory research programs. It is also the site of graduate medical education with a full complement of residency and fellowship training in the medical subspecialties. The Inova Fairfax campus houses the Department of Defense/ Walter Reed Specialized Research Center and is the new home for the Armed Forces Institute of Pathology, with AFIP physicians integrated into the fulltime Inova Medical Group. The AFIP performs over 10,000 opinion consults a year.

Their clinical research programs are significant with over 500 active protocols, including 239 treatment-related protocols, conducted by over 180 physicians. About 40% of this research is funded from commercial sources. Their largest volume of clinical trials involves pediatrics, oncology, cardiovascular and advanced lung disease. The Inova Translational Medicine Institute was established in 2010 and has a major focus on translating genomics research to individualized (personalized) healthcare, research and education for the diverse communities Inova serves.